CRANBURY, N.J.--(BUSINESS WIRE)--PER Global, the ex-US affiliate of Physicians’ Education Resource, the leading resource for oncology and hematology continuing medical education (CME), will host the second annual Paris Breast Cancer Conference™ from Nov. 16-17 at The Westin Paris-Vendômein Paris, France. The program will be co-chaired by Fabrice André, M.D., Ph.D., professor, department of medical oncology at Institut Gustave Roussy in Villejuif, France, and Nicholas Turner, M.D., Ph.D., academic consultant medical oncologist at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust NIHR Biomedical Research Centre, London, United Kingdom.
“We are excited to announce the second annual Paris Breast Cancer Conference™,” said Phil Talamo, president of PER® Global. “This conference will help practitioners place emerging information into the context of landmark clinical trial data and establish standards of care, with the goal of ultimately improving the care they provide to their patients with breast cancer.”
Designed for medical oncologists and other health care professionals, the second annual Paris Breast Cancer Conference™ is a practical and interactive multiday educational program that features a faculty of leading international experts who will provide up-to-date information and guidance via didactic lectures, question-and-answer sessions, and extended interactive, case-based panel discussions. This format will enable participants to engage the faculty in a direct exchange of perspectives, personal experiences and strategies related to clinical challenges in the management of breast cancers.
For more information and to register, visit https://www.gotoper.com/conferences/ecb/meetings/2nd-annual-paris-breast-cancer-conference.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas and continues to grow its therapeutic reach outside of oncology. While continuing to expand into topics outside of oncology, PER® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. In 2018, PER® will develop and implement 21 historic annual legacy conferences in the United States and Europe, along with many renowned online learning formats. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
